ECD, a novel androgen receptor target promotes prostate cancer tumorigenesis by regulating glycolysis
Mohsin Raza, Asher Rajkumar Rajan, Benjamin B. Kennedy, Timothy E. Reznicek, Farshid Oruji, Sameer Mirza, M. Jordan Rowley, Carsten Stephan, Glen Kristiansen, Kaustubh Datta, Bhopal C. Mohapatra, Hamid Band, Vimla Band
This study identifies ECD as a novel androgen receptor target that promotes prostate cancer by enhancing glycolysis and oncogenic traits.
Oncogene · Sep 4, 2025Peer-reviewedCancer Biology